Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
08/13/2002 | US6433451 Method and electric motor with rotational stator |
08/13/2002 | US6433155 Isolated cdna or rna polynucleotide comprising nucleic acid sequence encoding polypeptide comprising specified amino acid sequence, or fragment thereof |
08/13/2002 | US6433149 Compounds and methods for inhibiting cancer metastasis |
08/13/2002 | US6433148 Immunoglobulin antibodies with amino acid sequences |
08/13/2002 | US6433147 Immunoregulators of immune response, hybridoma, human immunoglobulin |
08/13/2002 | US6433143 Tie-2 ligands |
08/13/2002 | US6433140 Stable bactericidal permeability-increasing protein products and pharmaceutical compositions containing the same |
08/13/2002 | US6433139 Secreted protein HPEAD48 |
08/13/2002 | US6433138 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids |
08/13/2002 | US6432917 Anticancer agents |
08/13/2002 | US6432708 Human choline acetyltransferase |
08/13/2002 | US6432703 Isolated polynucleotide sequences |
08/13/2002 | US6432687 Polypeptide amino acid sequence with immunoactive segments |
08/13/2002 | US6432667 Polynucleotide encoding TIE-2 ligand-4 |
08/13/2002 | US6432664 Transformation to produce proteins with amino acid sequences |
08/13/2002 | US6432644 Diagnosing polymorphism in humans |
08/13/2002 | US6432640 P53-induced apoptosis |
08/13/2002 | US6432636 Detection and quantitation of splice perlecan domain gene |
08/13/2002 | US6432628 Detection of compounds, enzymes, polypeptides and detection of aspartic acid |
08/13/2002 | US6432407 Antigenic protein originating in malassezia |
08/13/2002 | US6432405 Method of inhibiting HIV infection with CD44 and anti-CD44 antibodies |
08/13/2002 | US6432404 Methods of inhibiting locomotor damage following spinal cord injury with α D-specific antibodies |
08/13/2002 | US6432403 Antibodies to polypeptides having prenylcysteine carboxyl methlytransferase activity or inhibiting activity |
08/13/2002 | US6432402 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof |
08/13/2002 | CA2328851C Humanized immunoglobulins and their production and use |
08/13/2002 | CA2045594C Immunogenic compositions against gastrin peptides |
08/13/2002 | CA2019671C Oxidative denaturation of protein analytes |
08/13/2002 | CA1341383C Further improvements relating to drug delivery systems |
08/08/2002 | WO2002061389A2 Methods to generate and identify monoclonal antibodies to a large number of human antigens |
08/08/2002 | WO2002061136A2 ISOLATED BOVINE IgG PROTEIN AND ITS USE AS AN ANTIMICROBIAL AGENT |
08/08/2002 | WO2002061105A2 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
08/08/2002 | WO2002061090A2 Prokaryotically produced antibodies and uses thereof |
08/08/2002 | WO2002061086A2 Human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1 |
08/08/2002 | WO2002061081A1 A novel gene bn01 mapping to chromosome 16q24.3 |
08/08/2002 | WO2002061076A1 Adiponectin-associated protein |
08/08/2002 | WO2002061071A2 Focused libraries of genetic packages |
08/08/2002 | WO2002061070A2 Environmentally regulated genes, involved in the virulence of streptococcus suis |
08/08/2002 | WO2002061057A2 Regulation of human wee1-like serine/threonine protein kinase |
08/08/2002 | WO2002061046A2 Novel nucleic acid and polypeptide molecules |
08/08/2002 | WO2002060955A2 Modified antibodies and methods of use |
08/08/2002 | WO2002060954A1 Materials and methods for treatment of hepatitis c |
08/08/2002 | WO2002060953A2 Nucleic acid and encoded zinc transporter protein entitled 108p5h8 useful in treatment and detection of cancer |
08/08/2002 | WO2002060950A2 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy |
08/08/2002 | WO2002060943A1 Human mitochondrial proteins and polynucleotides encoding the proteins |
08/08/2002 | WO2002060942A2 Protein modification and maintenance molecules |
08/08/2002 | WO2002060936A2 Vaccine and compositions for the prevention and treatment of neisserial infections |
08/08/2002 | WO2002060930A2 Method for the identification of extracellular domains of the epstein barr virus (ebv), tumor-associated latent membrane proteins and for the selection of antibody reagents reactive therewith |
08/08/2002 | WO2002060919A2 Molecules with extended half-lives, compositions and uses thereof |
08/08/2002 | WO2002060485A2 Use of immunoregulatory antibodies in the treatment of neoplastic disorders |
08/08/2002 | WO2002060484A1 Use of cd23 antagonists for the treatment of neoplastic disorders |
08/08/2002 | WO2002060481A1 Methods for treating disease states comprising administration of low levels of antibodies |
08/08/2002 | WO2002060480A1 Methods for treating or preventing skin disorders using cd2-binding agents |
08/08/2002 | WO2002060478A1 Methods for alleviating symptoms associated with diabetes and diabetic neuropathy comprising administration of low levels of antibodies |
08/08/2002 | WO2002046208A3 Method of producing biospecific molecules by protein trans-splicing |
08/08/2002 | WO2002042441A3 VON WILLEBRAND FACTOR (vWF) CLEAVING PROTEASE POLYPEPTIDE, NUCLEIC ACID ENCODING THE POLYPEPTIDE AND USE OF POLYPEPTIDE |
08/08/2002 | WO2002038597A3 Genomic fragment of streptococcus suis and clinical uses thereof |
08/08/2002 | WO2002034945A3 Estrogen receptor alpha variants and methods of detection thereof |
08/08/2002 | WO2002020762A3 Tnf receptor-like molecules and uses thereof |
08/08/2002 | WO2002014366A3 Genes involved in immune related responses observed with asthma |
08/08/2002 | WO2002002744A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
08/08/2002 | WO2002000840A3 Human lyases |
08/08/2002 | WO2002000695A3 Peptides for the preparation of vaccines against bordetella pertussis and bordetella parapertussis |
08/08/2002 | WO2001096546A3 Protein phosphatases |
08/08/2002 | WO2001096528A3 Human tumor necrosis factor delta and epsilon |
08/08/2002 | WO2001096393A3 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
08/08/2002 | WO2001092306A3 Therapeutic compounds for ovarian cancer |
08/08/2002 | WO2001090330A3 AMINOACYL tRNA SYNTHETASES |
08/08/2002 | WO2001085926A3 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate |
08/08/2002 | WO2001085784A9 POLYNUCLEOTIDES ENCODING FOR POLYMORPHIC ISOFORMS OF THE PTHrP PROTEIN, THE ENCODED PROTEINS AND THEIR THERAPEUTIC APPLICATIONS THEREOF |
08/08/2002 | WO2001081585A3 A thymus expressed human cytochrome p450 (p450tec) |
08/08/2002 | WO2001064905A3 2504, 15977, and 14760, novel protein kinase family members and uses therefor |
08/08/2002 | WO2001059152A9 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications |
08/08/2002 | WO2001051523A3 Anti-angiogenic proteins and fragments and methods of use thereof |
08/08/2002 | WO2001034802A9 Compositions and methods for the therapy and diagnosis of prostate cancer |
08/08/2002 | WO2001021799A9 Traf4 associated cell cycle proteins, compositions and methods of use |
08/08/2002 | WO2001013714A3 Prostatic cell line and animal model of a prostatic tumor |
08/08/2002 | WO2001009328A9 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
08/08/2002 | WO2001008636A8 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein |
08/08/2002 | US20020108149 Methods of increasing polypeptide accumulation in plants |
08/08/2002 | US20020108132 Production of a monoclonal antibody by a transgenic chicken |
08/08/2002 | US20020107869 Novel implant and novel vector for the treatment of acquired diseases |
08/08/2002 | US20020107385 Human breast tumor-specific proteins |
08/08/2002 | US20020107372 Nucleotide sequences coding membrane protein for use in the treatment of inflammation,lung defects and viral diseases |
08/08/2002 | US20020107370 Protein for use in the treatment of lzheimer's, parkinson's, amyotrophic lateral sclerosis, multiple sclerosis, retinopathy, brain, blood, myocardium, stroke, reperfusion injury and liver disorders |
08/08/2002 | US20020107369 Antibody for use in the treatment of cell proliferation defects |
08/08/2002 | US20020107368 Helicobacter proteins, gene sequences and uses thereof |
08/08/2002 | US20020107367 Preferential isolation egg yolk antibodiesisoforms; obtain egg yolk, incubate with salt, recover antibody isoforms |
08/08/2002 | US20020107363 B7-Like molecules and uses thereof |
08/08/2002 | US20020107361 Novel metalloproteases having thrombospondin domains and nucleic acid compositions encoding the same |
08/08/2002 | US20020107360 Hepatitis E virus antigens and uses therefor |
08/08/2002 | US20020107233 Useful for treating hypocholesterolemia |
08/08/2002 | US20020107226 Assays and reagents for identifying anti-fungal agnets, amd uses related thereto |
08/08/2002 | US20020107211 Ob polypeptides; treating obesity; antagonists thereof to increase weight |
08/08/2002 | US20020107194 Able to bind to a Notch protein forming Delta-Notch complex |
08/08/2002 | US20020107186 Isolated NOVX polynucleotides and polypeptides encoded by them |
08/08/2002 | US20020107180 Cell surface glycoproteins |
08/08/2002 | US20020106799 Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells |
08/08/2002 | US20020106798 Plasmid for use in vaccination of animals aganist fungal, bacterial and viral infections |
08/08/2002 | US20020106780 Extracellular matrix polynucleotides, polypeptides, and antibodies |
08/08/2002 | US20020106778 Human PTTG polypeptide and method for producing it |